An Unmutated Hypereosinophilic Syndrome Case That is Succesfully Treated with Imatinib Mesylate

E. Saribacak Can; U. Malkan; M. Albayrak; G. Gunes

An Unmutated Hypereosinophilic Syndrome Case That is Succesfully Treated with Imatinib Mesylate

E. Saribacak Can
, U. Malkan
, M. Albayrak
, G. Gunes

İç Hastalıkları Anabilim Dalı

Araştırma sonucu: Dergiye katkı › Toplantı Özeti › bilirkişi

Orijinal dil	İngilizce
Sayfa (başlangıç-bitiş)	S41-S41
Sayfa sayısı	1
Dergi	Leukemia Research
Hacim	61
Yayın durumu	Yayınlandı - Eki 2017
Etkinlik	8th International Eurasian Hematology Oncology Congress (EHOC) - Istanbul, !!Turkey Süre: 18 Eki 2017 → 21 Eki 2017

Diger dosyalar ve linkler

???wos.publication.link???

Bundan alıntı yap

@article{ea7ee46671c14b658f0cf8d4af8e69df,

title = "An Unmutated Hypereosinophilic Syndrome Case That is Succesfully Treated with Imatinib Mesylate",

author = "Can, \{E. Saribacak\} and U. Malkan and M. Albayrak and G. Gunes",

year = "2017",

month = oct,

language = "English",

volume = "61",

pages = "S41--S41",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Ltd",

note = "8th International Eurasian Hematology Oncology Congress (EHOC) ; Conference date: 18-10-2017 Through 21-10-2017",

}

TY - JOUR

T1 - An Unmutated Hypereosinophilic Syndrome Case That is Succesfully Treated with Imatinib Mesylate

AU - Can, E. Saribacak

AU - Malkan, U.

AU - Albayrak, M.

AU - Gunes, G.

PY - 2017/10

Y1 - 2017/10

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=performanshacettepe&SrcAuth=WosAPI&KeyUT=WOS:000416742600109&DestLinkType=FullRecord&DestApp=WOS_CPL

M3 - Meeting Abstract

SN - 0145-2126

VL - 61

SP - S41-S41

JO - Leukemia Research

JF - Leukemia Research

T2 - 8th International Eurasian Hematology Oncology Congress (EHOC)

Y2 - 18 October 2017 through 21 October 2017

ER -